Stefan A J Buck (Stefan Buck)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Locally Advanced

Radical Prostatectomy

Prognostic Factors

Ejection Fraction

Top Venues

International journal of cancer

Therapeutic advances in medical oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Stefan A J Buck, Zahra Talebi, Thomas Drabison, Yan Jin, Alice A Gibson, Peng Hu, Peter de Bruijn, Corrina M A de Ridder, Debra Stuurman, Shuiying Hu, Wytske M van Weerden, Stijn L W Koolen, Ronald de Wit, Alex Sparreboom, Ron H J Mathijssen, Eric D Eisenmann
Darolutamide does not interfere with OATP-mediated uptake of docetaxel. International journal of cancer 155 (2) (2024)
Stefan A J Buck, Zahra Talebi, Thomas Drabison, Yan Jin, Alice A Gibson, Peng Hu, Peter de Bruijn, Corrina M A de Ridder, Debra Stuurman, Shuiying Hu, Wytske M van Weerden, Stijn L W Koolen, Ronald de Wit, Alex Sparreboom, Ron H J Mathijssen, Eric D Eisenmann
Darolutamide does not interfere with OATP-mediated uptake of docetaxel. International journal of cancer (2024)
Stefan A J Buck, Annelies Van Hemelryk, Corrina de Ridder, Debra Stuurman, Sigrun Erkens-Schulze, Sem Van 't Geloof, Wilma J Teubel, Stijn L W Koolen, Elena S Martens-Uzunova, Martin E van Royen, Ronald de Wit, Ron H J Mathijssen, Thomas A Kirkland
Darolutamide added to docetaxel augments antitumor effect in models of prostate cancer through cell cycle arrest at the G1-S transition. Molecular cancer therapeutics (2023)
Aurelius G Omlin, Richard Cathomas, Gunhild von Amsberg, Christoph Reuter, Susan Feyerabend, Wolfgang Loidl, Martin Boegemann, Anja Lorch, Axel Heidenreich, Igor Tsaur, Julian Larcher-Senn, Stefan A J Buck, Ron H J Mathijssen, Ulrich Jaehde, Silke Gillessen Sommer, Markus Joerger
Randomized phase 2 Cabazitaxel dose individualization and Neutropenia prevention Trial (CAINTA) in patients with metastatic castration-resistant prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Stefan A J Buck, C Louwrens Braal, Maaike M Hofman, Esther Oomen-de Hoop, Peter de Bruijn, Inge M Ghobadi Moghaddam-Helmantel, Koen G A M Hussaarts, Mijntje B Vastbinder, Quirine C van Rossum-Schornagel, Ron H N van Schaik, Agnes Jager, Stijn L W Koolen, Ron H J Mathijssen
Influence of probenecid on endoxifen systemic exposure in breast cancer patients on adjuvant tamoxifen treatment. Therapeutic advances in medical oncology 14 (2022)
Stefan A J Buck, Niels A D Guchelaar, Peter de Bruijn, Inge M Ghobadi Moghaddam-Helmantel, Esther Oomen-de Hoop, Hans M Westgeest, Paul Hamberg, Danielle Mathijssen-van Stein, Martijn P Lolkema, Stijn L W Koolen, Ronald de Wit, Ron H J Mathijssen
Influence of Darolutamide on Cabazitaxel Systemic Exposure. Clinical pharmacokinetics 61 (10) (2022)